Gujarat Terce Laboratories Ltd Quarterly Results
Q2 FY21-22 Results Summary
Revenue
The revenue stands at ₹10.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.91 per cent from ₹9.94 crore. This corresponds to a year-on-year *(YoY) growth of 8.46 per cent.
Operating Profit
Operating Profit stands at ₹0.54 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 66.87 per cent from ₹1.63 crore. This corresponds to a year-on-year *(YoY) growth of 208.00 per cent.
PBDT
PBDT stands at ₹0.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 69.70 per cent from ₹1.65 crore. This corresponds to a year-on-year *(YoY) growth of 247.06 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.88 per cent from ₹1.60 crore. This corresponds to a year-on-year *(YoY) growth of 209.76 per cent.
Net Profit
Net Profit stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.88 per cent from ₹1.60 crore. This represents a 178.95 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gujarat Terce Laboratories Ltd Earnings
- YOY
- QOQ
Gujarat Terce Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gujarat Terce Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gujarat Terce Laboratories Ltd Financial Reports
Gujarat Terce Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Guj. Terce Labs. | 4.18% | 2.36% | 6.53% | 14.85% | -14.14% | -27.60% |
| Panjon | 2.01% | 4.34% | -12.51% | -24.64% | 5.98% | -4.00% |
| Medico Intercon. | 1.17% | 1.26% | 48.10% | 16.74% | -21.88% | -19.71% |
| Parmax Pharma | 2.00% | 6.11% | 100.28% | 148.52% | 130.89% | 100.28% |
| Remedium Life | 3.33% | 3.33% | -16.22% | -11.43% | -58.67% | -69.61% |
| Ishita Drugs | 4.05% | 4.17% | -5.48% | 8.99% | -3.75% | -6.05% |
| Shree Ganesh Bio | -1.72% | -1.72% | -5.00% | -1.72% | -8.06% | -33.72% |
Company Info
Company Information
Whole-time Director : Amrutbhai P Prajapati
Independent Director : Chhayaben Ashwinbhai Shah
Independent Director : Viplav Suryakantbhai Khamar
Managing Director & Chief Executive Officer : Aalap Prajapati
Independent Director : Surendra Kumar Sharma
Chairman & Wholetime Director : Natwarbhai P Prajapati
Independent Director : Avani Vishnubhai Patel
Company Sec. & Compli. Officer : Ripalben Sachinkumar Sukhadiya